Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2007 Dec 14;228(1):68–75. doi: 10.1016/j.taap.2007.11.031

Figure 5.

Figure 5

Morphological changes in the kidneys of MRL +/+ mice treated with TCE for 48 weeks. A. Control, H&E stain. B. TCE-treated: the arrow indicates perivascular inflammatory infiltrates. C. Control, CD3-stain. D. TCE-treated: the arrow indicates CD3-positive lymphocytes (A–D, x200).